Inhibikase Therapeutics, Inc.盘中异动早盘急速拉升5.31%

市场透视12-11

北京时间2024年12月11日22时40分，Inhibikase Therapeutics, Inc.（IKT.us）股票出现异动，股价急速上涨5.31%。截至发稿，该股报3.37美元/股，成交量1.5063万股，换手率0.02%，振幅6.56%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-5.78百万美元，每股收益-0.65美元，毛利-6568.00美元，市盈率-1.07倍。机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2490976863?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-11 22:40","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2490976863","market":"us","top_or_hot":-1,"title":"Inhibikase Therapeutics, Inc.盘中异动 早盘急速拉升5.31%","media":"市场透视","content":"<div>\n<p>北京时间2024年12月11日22时40分，Inhibikase Therapeutics, Inc.（IKT.us）股票出现异动，股价急速上涨5.31%。截至发稿，该股报3.37美元/股，成交量1.5063万股，换手率0.02%，振幅6.56%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-5.78百万美元，每股收益-0.65美元，毛利-6568.00美元，市盈率-1.07倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211224031a1e66ee7&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inhibikase Therapeutics, Inc.盘中异动 早盘急速拉升5.31%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInhibikase Therapeutics, Inc.盘中异动 早盘急速拉升5.31%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-11 22:40 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211224031a1e66ee7&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年12月11日22时40分，Inhibikase Therapeutics, Inc.（IKT.us）股票出现异动，股价急速上涨5.31%。截至发稿，该股报3.37美元/股，成交量1.5063万股，换手率0.02%，振幅6.56%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-5.78百万美元，每股收益-0.65美元，毛利-6568.00美元，市盈率-1.07倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211224031a1e66ee7&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211224031a1e66ee7&s=b","article_id":"2490976863","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211224031a1e66ee7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2490976863","pubTimestamp":1733928031,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年12月11日22时40分，Inhibikase Therapeutics, Inc.股票出现异动，股价急速上涨5.31%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LENZ":"Therapeutics","BK4139":"生物科技","IKT":"Inhibikase Therapeutics, Inc."},"translate_title":"Inhibikase Therapeutics, Inc. surged 5.31% in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IKT":1,"LENZ":1},"content_text":"北京时间2024年12月11日22时40分，Inhibikase Therapeutics, Inc.（IKT.us）股票出现异动，股价急速上涨5.31%。截至发稿，该股报3.37美元/股，成交量1.5063万股，换手率0.02%，振幅6.56%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-5.78百万美元，每股收益-0.65美元，毛利-6568.00美元，市盈率-1.07倍。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Candel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts (01/12/2026) To Pur Com、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 (To Pur Com)涨幅较大，Silexion Therapeutics Corp、Candel Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为381.87%、122.36%、99.32%，振幅较大的相关个股有Candel Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、Apollomics Inc C/Wts 01/04/2028 (To Pur Ord)，振幅分别为53.79%、48.81%、29.79%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病（PD），帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。其多治疗产品线主要关注神经退行性疾病，其项目利用 Risvodetinib（也称为 IkT-148009），一种非受体 Abelson 酪氨酸激酶的选择性抑制剂，也针对大脑内部和外部的帕金森病的治疗以及由阿贝尔森酪氨酸激酶引起的其他疾病。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2490976863"}

Inhibikase Therapeutics, Inc.盘中异动 早盘急速拉升5.31%

精彩评论

Inhibikase Therapeutics, Inc.盘中异动早盘急速拉升5.31%